Ketamine Augmentation for Major Depressive Disorder and Suicidal Ideation: Preliminary Experience in an Inpatient Psychiatry Setting

There is a growing body of evidence demonstrating that intravenous ketamine infusions can provide rapid relief of depressive symptoms in people suffering from treatment-resistant major depressive disorder (MDD) as well as bipolar depression with various studies showing rapid response to a single infusion which persists for at least 72 hours (Aan Het Rot et  al. 2012; DiazGranados et al. 2010; George et al. 2017; Ibrahim et al. 2011; Mathew et al. 2012; Murrough et al. 2013a; Singh et al. 2016; Su et al.

Source: Journal of Affective Disorders - July 27, 2018 Category: Neurology Authors: Mark Sinyor, Marissa Williams, Sue Belo, Beverley Orser, Margaret Vincent, Linda Mah, Carlos Zarate, Saulo Castel, Anthony J. Levitt, Ayal Schaffer Tags: Research paper Source Type: research